Medical Xpress·4 min read·hard
Fibronectin pathway may drive Marfan aortic damage, opening new drug targets
S
Spanish National Research Council
✦AI Summary
Researchers have identified a molecular pathway involving the protein fibronectin that contributes to aortic damage in Marfan syndrome. This discovery offers potential new targets for pharmacological treatments to prevent aortic rupture.
Why it matters
Current treatments for Marfan syndrome are limited to surgery; identifying drug targets could significantly improve patient outcomes and quality of life.
edited by Gaby Clark , reviewed by Andrew Zinin
healthscience
Political Bias
Center
LeftLean LCenterLean RRight
Confidence: 95%
The article is a summary of scientific research findings published in a peer-reviewed journal.
✦
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in